NLX-112, a novel 5-HT1A receptor agonist for the treatment of l-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat

Autor: Iderberg, H., McCreary, A.C., Varney, M.A., Kleven, M.S., Koek, W., Bardin, L., Depoortère, R., Cenci, M.A., Newman-Tancredi, A.
Zdroj: In Experimental Neurology September 2015 271:335-350
Databáze: ScienceDirect
Externí odkaz: